These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 18823260)

  • 41. Parametric two-tier sequential quality assurance test of delivery dose uniformity of multiple-dose inhaler and dry powder inhaler drug products.
    Tsong Y; Shen M; Lostritto RT; Poochikian GK
    J Biopharm Stat; 2008; 18(5):976-84. PubMed ID: 18781529
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Breath-synchronized plume-control inhaler for pulmonary delivery of fluticasone propionate.
    Shrewsbury SB; Armer TA; Newman SP; Pitcairn G
    Int J Pharm; 2008 May; 356(1-2):137-43. PubMed ID: 18289809
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evaluation of in vitro in vivo correlations for dry powder inhaler delivery using artificial neural networks.
    de Matas M; Shao Q; Richardson CH; Chrystyn H
    Eur J Pharm Sci; 2008 Jan; 33(1):80-90. PubMed ID: 18035525
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evaluation of supercritical fluid engineered budesonide powder for respiratory delivery using nebulisers.
    Amani A; Chrystyn H; Clark BJ; Abdelrahim ME; York P
    J Pharm Pharmacol; 2009 Dec; 61(12):1625-30. PubMed ID: 19958584
    [TBL] [Abstract][Full Text] [Related]  

  • 45. NanoCluster budesonide formulations enable efficient drug delivery driven by mechanical ventilation.
    Pornputtapitak W; El-Gendy N; Mermis J; O'Brien-Ladner A; Berkland C
    Int J Pharm; 2014 Feb; 462(1-2):19-28. PubMed ID: 24374223
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Problems with inhaler use: a call for improved clinician and patient education.
    Fink JB; Rubin BK
    Respir Care; 2005 Oct; 50(10):1360-74; discussion 1374-5. PubMed ID: 16185371
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [The relationship between inspiratory pressure and flow through dry powder inhaler available in Japan].
    Kondo T; Tanigaki T; Tazaki G; Watanabe H; Ishii H; Tsunoda T; Uruma T
    Arerugi; 2010 Aug; 59(8):950-5. PubMed ID: 20820136
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pulmicort flexhaler dose confusion.
    Nursing; 2009 Mar; 39(3):12. PubMed ID: 19247100
    [No Abstract]   [Full Text] [Related]  

  • 49. Is inhalation rate important for a dry powder inhaler? Using the In-Check Dial to identify these rates.
    Chrystyn H
    Respir Med; 2003 Feb; 97(2):181-7. PubMed ID: 12587970
    [TBL] [Abstract][Full Text] [Related]  

  • 50. What plays a role in the choice of inhaler device for asthma therapy?
    Virchow JC
    Curr Med Res Opin; 2005; 21 Suppl 4():S19-25. PubMed ID: 16138941
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Scintigraphic evaluation of lung deposition with a novel inhaler device.
    Newman SP; Hirst PH; Pitcairn GR
    Curr Opin Pulm Med; 2001 Apr; 7 Suppl 1():S12-4. PubMed ID: 11385810
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Usefulness of peak expiratory flow measurement for selection of dry powder inhalers in asthmatic children].
    Emeryk A; Bartkowiak-Emeryk M; Czerwińska-Pawluk I; Postepski J
    Pol Merkur Lekarski; 2000 Oct; 9(52):667-70. PubMed ID: 11144053
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Inhaler technique in older people in the community.
    Ho SF; OMahony MS; Steward JA; Breay P; Burr ML
    Age Ageing; 2004 Mar; 33(2):185-8. PubMed ID: 14960436
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Selection of a personal dry powder inhaler based on peak inspiratory flow measurements in selected groups of patients with bronchial obstruction].
    Kokot M
    Pol Merkur Lekarski; 2000 Oct; 9(52):672-6. PubMed ID: 11144054
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Automatic actuation of a dry powder inhaler into a nonelectrostatic spacer.
    Bisgaard H
    Am J Respir Crit Care Med; 1998 Feb; 157(2):518-21. PubMed ID: 9476867
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [A new breath actuated dry powder inhaler (Auto-Jethaler)].
    Steiss JO; Heckmann M; Jödicke B; Landmann E; Schüler D; Weber K; Pabst J; Lindemann H
    Klin Padiatr; 2007; 219(2):66-9. PubMed ID: 16878285
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Delivery of salbutamol and of budesonide from a novel multi-dose inhaler Airmax.
    Zeng XM; O'Leary D; Phelan M; Jones S; Colledge J
    Respir Med; 2002 Jun; 96(6):404-11. PubMed ID: 12117039
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Discrepancy between in vitro and in vivo dose variability for a pressurized metered dose inhaler and a dry powder inhaler.
    Borgström L; Asking L; Beckman O; Bondesson E; Källén A; Olsson B
    J Aerosol Med; 1998; 11 Suppl 1():S59-64. PubMed ID: 10180734
    [No Abstract]   [Full Text] [Related]  

  • 59. Effect of processing history on the surface interfacial properties of budesonide in carrier-based dry-powder inhalers.
    Shur J; Pitchayajittipong C; Rogueda P; Price R
    Ther Deliv; 2013 Aug; 4(8):925-37. PubMed ID: 23919472
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Dry powder inhalers (DPIs)--a review of device reliability and innovation.
    Islam N; Gladki E
    Int J Pharm; 2008 Aug; 360(1-2):1-11. PubMed ID: 18583072
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.